Open Access
,
volume 6
Voltage-gated sodium channels and cancer: is excitability their primary role?
1
2
Université de Bern, Department of clinical research, Bern, Switzerland
|
Publication type: Journal Article
Publication date: 2015-07-29
scimago Q1
wos Q1
SJR: 1.220
CiteScore: 8.9
Impact factor: 4.8
ISSN: 16639812
PubMed ID:
26283962
Pharmacology
Pharmacology (medical)
Abstract
Voltage-gated sodium channels (NaV) are molecular characteristics of excitable cells. Their activation, triggered by membrane depolarization, generates transient sodium currents that initiate action potentials in neurons and muscle cells. Sodium currents were discovered by A. Hodgkin and A. Huxley using the voltage clamp technique and reported in their landmark series of papers in 1952. It was only in the 1980's that sodium channel proteins from excitable membranes were molecularly characterized by W. Catterall and his collaborators. Non-excitable cells can also express NaV channels in physiological conditions as well as in pathological conditions. These NaV channels can sustain biological roles that are not related to the generation of action potentials. Interestingly, it is likely that the abnormal expression of Na¬V in pathological tissues can reflect the re-expression of a fetal phenotype. This is especially true in epithelial cancer cells for which these channels have been identified and sodium currents recorded, while it was not the case for cells from the cognate normal tissues. In cancers, the functional activity of NaV appeared to be involved in regulating the proliferative, migrative and invasive properties of cells. This review is aimed at addressing the non-excitable roles of NaV channels with a specific emphasis in the regulation of cancer cell biology.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
|
|
|
International Journal of Molecular Sciences
5 publications, 5%
|
|
|
Scientific Reports
5 publications, 5%
|
|
|
Cancers
4 publications, 4%
|
|
|
Toxins
3 publications, 3%
|
|
|
Frontiers in Pharmacology
3 publications, 3%
|
|
|
Frontiers in Oncology
2 publications, 2%
|
|
|
Cell Calcium
2 publications, 2%
|
|
|
Bioorganic and Medicinal Chemistry
2 publications, 2%
|
|
|
Seminars in Cancer Biology
2 publications, 2%
|
|
|
International Journal of Cancer
2 publications, 2%
|
|
|
Channels
2 publications, 2%
|
|
|
Reviews of Physiology Biochemistry and Pharmacology
2 publications, 2%
|
|
|
Oncology
1 publication, 1%
|
|
|
Bioelectricity
1 publication, 1%
|
|
|
Journal of General Virology
1 publication, 1%
|
|
|
International Journal of Oncology
1 publication, 1%
|
|
|
Oncology Reports
1 publication, 1%
|
|
|
Cells
1 publication, 1%
|
|
|
Journal of Personalized Medicine
1 publication, 1%
|
|
|
Frontiers in Neuroscience
1 publication, 1%
|
|
|
Stem Cell Research and Therapy
1 publication, 1%
|
|
|
European Biophysics Journal
1 publication, 1%
|
|
|
Nature Communications
1 publication, 1%
|
|
|
Molecular Cancer
1 publication, 1%
|
|
|
Communications Biology
1 publication, 1%
|
|
|
Cell and Bioscience
1 publication, 1%
|
|
|
BMC Research Notes
1 publication, 1%
|
|
|
Computers in Biology and Medicine
1 publication, 1%
|
|
|
Physics of Life Reviews
1 publication, 1%
|
|
|
1
2
3
4
5
|
Publishers
|
5
10
15
20
25
|
|
|
Elsevier
24 publications, 24%
|
|
|
Springer Nature
17 publications, 17%
|
|
|
MDPI
15 publications, 15%
|
|
|
Wiley
13 publications, 13%
|
|
|
Frontiers Media S.A.
7 publications, 7%
|
|
|
Cold Spring Harbor Laboratory
5 publications, 5%
|
|
|
Spandidos Publications
2 publications, 2%
|
|
|
Taylor & Francis
2 publications, 2%
|
|
|
S. Karger AG
1 publication, 1%
|
|
|
Mary Ann Liebert
1 publication, 1%
|
|
|
Microbiology Society
1 publication, 1%
|
|
|
Public Library of Science (PLoS)
1 publication, 1%
|
|
|
The Royal Society
1 publication, 1%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 1%
|
|
|
1 publication, 1%
|
|
|
Oxford University Press
1 publication, 1%
|
|
|
American Physiological Society
1 publication, 1%
|
|
|
The Company of Biologists
1 publication, 1%
|
|
|
IntechOpen
1 publication, 1%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
1 publication, 1%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 1%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 1%
|
|
|
5
10
15
20
25
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
100
Total citations:
100
Citations from 2025:
11
(11%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Roger S. et al. Voltage-gated sodium channels and cancer: is excitability their primary role? // Frontiers in Pharmacology. 2015. Vol. 6.
GOST all authors (up to 50)
Copy
Roger S., Gillet L., Le Guennec J., Besson P. Voltage-gated sodium channels and cancer: is excitability their primary role? // Frontiers in Pharmacology. 2015. Vol. 6.
Cite this
RIS
Copy
TY - JOUR
DO - 10.3389/fphar.2015.00152
UR - https://doi.org/10.3389/fphar.2015.00152
TI - Voltage-gated sodium channels and cancer: is excitability their primary role?
T2 - Frontiers in Pharmacology
AU - Roger, Sã©bastien
AU - Gillet, Ludovic
AU - Le Guennec, Jean-Yves
AU - Besson, Pierre
PY - 2015
DA - 2015/07/29
PB - Frontiers Media S.A.
VL - 6
PMID - 26283962
SN - 1663-9812
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2015_Roger,
author = {Sã©bastien Roger and Ludovic Gillet and Jean-Yves Le Guennec and Pierre Besson},
title = {Voltage-gated sodium channels and cancer: is excitability their primary role?},
journal = {Frontiers in Pharmacology},
year = {2015},
volume = {6},
publisher = {Frontiers Media S.A.},
month = {jul},
url = {https://doi.org/10.3389/fphar.2015.00152},
doi = {10.3389/fphar.2015.00152}
}